Key result
Fontan procedure yields no morbidity or mortality in patients with preoperative pulmonary artery pressure >15 mmHg.
Why the study?
High pulmonary artery pressure remains one of the most important limitations for proceeding to a Fontan circulation.
Does stage III Fontan completion result in acceptable morbidity and mortality in patients with preoperative mean pulmonary artery pressure > 15 mmHg?
Cohort (n=16)
Does stage III Fontan completion result in acceptable morbidity and mortality in patients with preoperative mean pulmonary artery pressure > 15 mmHg?
Stage III Fontan completion can be performed safely with encouraging mid-term survival and hemodynamic outcomes in selected patients with preoperative mean pulmonary artery pressure > 15 mmHg.
Caution against relaxing mPAP thresholds for Fontan; leaves open generalizability and need for prospective trials.
Background: Several factors affect the long-term outcome of Fontan procedure, but a high pulmonary artery pressure is still one of the most important limitation for proceeding to a Fontan circulation. Herein, we present our experience in Fontan patients with high preoperative pulmonary artery pressures. Methods: A retrospective analysis was performed in order to evaluate Fontan patients with a preoperative pulmonary artery pressure > 15 mmHg between 2009 and 2020. Sixteen patients were operated on with a mean preoperative pulmonary artery pressure of 17.5 ± 2.1 mmHg. Results: Mean age at the time of Fontan procedure was 7.8 ± 5.6 years. All of the patients had stage II cavopulmonary anastomosis prior to Fontan completion, with a mean interstage period of 4 ± 2.6 years. Fontan completion was achieved with a polytetrafluorethylene (PTFE) tubular conduit, two of which were intra-extracardiac. Fenestration was performed in 4 (25%) cases. Postoperative pulmonary artery pressures and arterial oxygen saturation levels were 11.2 ± 2.8 mmHg and 97.8 ± 2, respectively. Mean duration of pleural drainage was 3.9 ± 5.3 days. Any morbidity and mortality were not encountered during a mean follow up period of 4.8 ± 7.7 years. Conclusions: The mid-term results of stage III Fontan completion in patients with pulmonary artery >15 mmHg are encouraging. Pulmonary vascular resistance, not only pulmonary artery pressure may help to identify high risk patients before Fontan completion.
No takes yet. Share an insight, caveat, or question.
Özyüksel et al. (2020) conducted a cohort in High preoperative pulmonary artery pressure requiring Fontan procedure (n=16). Fontan procedure was evaluated on Morbidity and mortality. The Fontan procedure in patients with preoperative pulmonary artery pressure >15 mmHg resulted in zero morbidity and mortality over a mean follow-up of 4.8 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: